4.8 Article

Adult attention-deficit hyperactivity disorder is associated with alterations in circadian rhythms at the behavioural, endocrine and molecular levels

期刊

MOLECULAR PSYCHIATRY
卷 17, 期 10, 页码 988-995

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/mp.2011.149

关键词

ADHD; BMAL1; circadian; cortisol; melatonin; PER2

资金

  1. AstraZeneca
  2. Bristol-Meyer Squibb
  3. Janssen
  4. Lilly
  5. Lundbeck
  6. MEDICE
  7. Merz
  8. Novartis
  9. Pfizer
  10. Servier
  11. Welsh Office for Research and Development
  12. NARSAD
  13. Medical Research Council [G0700102] Funding Source: researchfish
  14. MRC [G0700102] Funding Source: UKRI

向作者/读者索取更多资源

Attention-deficit hyperactivity disorder (ADHD) in adults is associated with impaired sleep, and it has been postulated that this impairment may contribute to the psychopathology of this common condition. One key driver of sleep/wake cycles is the circadian system, which at the molecular level consists of a series of transcriptional feedback loops of clock genes, which in turn produce endocrine, physiological and behavioural outputs with a near 24 h periodicity. We set out to examine circadian rhythms at the behavioural, endocrine and molecular levels in ADHD. Adults with ADHD as well as age- and sex-matched controls were recruited. Circadian rhythms were measured by means of actigraphy for the determination of gross motor patterns, by self-sampling of oral mucosa for assessment of rhythmic expression of the clock genes BMAL1 and PER2, and by estimation of salivary cortisol and melatonin levels. Actigraphic analysis revealed significant diurnal and nocturnal hyperactivity in the ADHD group, as well as a significant shorter period of best fit for the locomotor circadian rhythm in ADHD. BMAL1 and PER2 showed circadian rhythmicity in controls with this being lost in the ADHD group. Cortisol rhythms were significantly phase delayed in the ADHD group. These findings indicate that adult ADHD is accompanied by significant changes in the circadian system, which in turn may lead to decreased sleep duration and quality in the condition. Further, modulation of circadian rhythms may represent a novel therapeutic avenue in the management of ADHD. Molecular Psychiatry (2012) 17, 988-995; doi:10.1038/mp.2011.149; published online 22 November 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据